Societal CDMO, Inc. Patent Applications Rejected
1 applications abandoned without a patent; the status gives the reason, newest filing first, as the USPTO Open Data Portal records them; the company is the first-named applicant. The application number opens the full record at Patent Center.
- 2013-07-12: Application 13941076; Invention NANOPARTICULATE MELOXICAM FORMULATIONS; Applicant Recro Pharma, Inc.; Status Abandoned -- Failure to Respond to an Office Action.
| Filed | Application | Invention | Applicant | Status | Published as | Inventor name | Inventor country | Examiner |
|---|---|---|---|---|---|---|---|---|
| 2013-07-12 | 13941076 | NANOPARTICULATE MELOXICAM FORMULATIONS | Recro Pharma, Inc. | Abandoned -- Failure to Respond to an Office Action | US20140141083A1 | Eugene R. Cooper Tuula Ryde John Pruitt Laura Kline | United States United States United States United States | TRAN, SUSAN T |